Zenoxa OD 600 Tablet SR contains Oxcarbazepine 600 mg as its active ingredient and is formulated as a sustained-release tablet to provide prolonged therapeutic effects. Oxcarbazepine is an anticonvulsant and mood-stabilizing agent primarily indicated for the management of partial seizures in adults and children aged six years and above. The mechanism of action involves the blockade of voltage-sensitive sodium channels, stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing the propagation of seizure activity. Zenoxa OD 600 Tablet SR is designed for once-daily dosing, enhancing patient compliance by maintaining steady plasma drug concentrations over an extended period. It is also utilized as adjunctive therapy in the treatment of generalized tonic-clonic seizures and has shown efficacy in mood disorders such as bipolar disorder. Common adverse effects may include dizziness, somnolence, headache, nausea, and hyponatremia; therefore, regular monitoring of serum sodium levels is recommended during therapy. Caution is advised in patients with hepatic or renal impairment. Zenoxa OD 600 Tablet SR should be prescribed and administered under medical supervision, with dosage adjustments tailored to individual patient response and tolerability to optimize therapeutic outcomes while minimizing adverse effects.